Xinjing Ding
Jiujiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Case Report: Popliteal arterial tumor embolus as the initial presentation of EGFR-mutant lung adenocarcinoma with pulmonary-vein invasion.
Journal: Frontiers in oncology
Published: October 23, 2025
Relationship Between the Proportion of CD24+ CD27+ B Cells And Lung Adenocarcinoma: Evidence From Mendelian Randomization And Single-Cell Analyses.
Journal: Current medicinal chemistry
Published: September 19, 2025
Combining recombinant human endostatin with third-generation EGFR-TKIs in advanced EGFR-sensitive mutant non-small cell lung cancer.
Journal: Journal of thoracic disease
Published: June 18, 2025
EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review.
Journal: Respiratory medicine case reports
Published: October 23, 2024
Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer.
Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer.
Journal: Technology in cancer research & treatment
Published: April 24, 2024
Anlotinib plus tislelizumab for recurrent metastatic pancreas ductal adenocarcinoma with germline BRCA2 mutation: A case report.
Journal: Experimental and therapeutic medicine
Published: November 28, 2023
Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications.
Journal: Materials today. Bio
Published: September 30, 2023
Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy.
Journal: Frontiers in immunology
Published: August 10, 2023
Immunotherapy-based therapy as a promising treatment for EGFR-mutant advanced non-small cell lung cancer patients after EGFR-TKI resistance.
Journal: Expert review of anticancer therapy
Published: January 19, 2023
Aumolertinib challenge as an optional treatment in advanced non small-cell lung cancer after osimertinib failure with epidermal growth factor receptor-sensitive mutation: A case series.
Journal: Oncology letters
Published: June 23, 2022
Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 22, 2021
Last Updated: 09/26/2026